Purchase Order 75N93021P01443
- Not listed
- The U.S. National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services, awarded a $4,094.11 firm-fixed-price purchase order to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. This award does not have a set-aside designation. The award supports Qiagen's provision of products and services to NIAID, such as DNA/RNA extraction kits, next-generation sequencing equipment, digital PCR systems, and bioinformatics...
- This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Qiagen, LLC, a division of the multinational biotechnology company Qiagen N.V. The $7,820.97 award supports the provision of Qiagen's products and services, which include DNA/RNA extraction kits, next-generation sequencing equipment, digital PCR systems, sample preparation instruments, bioinformatics software, and precision medicine analysis tools. Qiagen has a long history...
- This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services (HHS), to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. The $11,437.12 contract is for the purchase of QIAGEN KITS & SUPPLIES, which are likely molecular biology products and services used to support NIAID's biomedical research, public health, and healthcare programs. Qiagen is an...
- This contract award is for the purchase of QIAGEN KITS from Qiagen, LLC, a subsidiary of the multinational biotechnology company Qiagen N.V. The $14,673.60 firm fixed price contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the Department of Health and Human Services (HHS). This purchase order contract does not have a set-aside designation. Qiagen provides a range of sample and assay technologies, including DNA/RNA extraction kits,...
- This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. The $5,749.20 firm-fixed-price purchase order is for the delivery of PCR arrays, reagents, and kits. The contract was awarded on September 18, 2014 and has an ultimate completion date of September 24, 2014. This award does not have a...
- This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services (HHS), to Qiagen, LLC, a subsidiary of the international biotechnology company Qiagen N.V. The $8,561.32 firm fixed-price purchase order is for the delivery of DNA purification kits, with a completion date of July 16, 2012. Qiagen is a provider of sample and assay technologies for molecular diagnostics, applied testing, pharma, and...
- This is a federal purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Qiagen, LLC, a subsidiary of the international biotechnology company Qiagen N.V. The $9,445.00 firm fixed-price contract does not have a set-aside designation. The contract supports NIAID's biomedical research, public health, and healthcare programs through the provision of Qiagen's sample and assay technologies, including...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $17,044.72 firm fixed-price purchase order to Qiagen, LLC, a division of the international provider Qiagen N.V. The order is for 2 kits of HOTSTARTAQ DNA POLYMERASE (25000). There is no set-aside designation noted. Qiagen has provided a range of products and services to various federal agencies, including DNA/RNA extraction kits, next-generation sequencing,...
- This federal contract award is for laboratory equipment and supplies provided by Qiagen, LLC, a subsidiary of the multinational biotechnology company Qiagen N.V. The contract, with a ceiling value of $27,785.90, was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services. The contract is a firm fixed-price purchase order with a completion date of June 17, 2016. This award is not associated with a set-aside program....
- The National Institute of Allergy and Infectious Diseases, a civilian agency within the Department of Health and Human Services, awarded a firm fixed-price purchase order worth $9,329.75 to Qiagen, LLC for a tissue lyser and adapter set. This award is associated with a larger contract vehicle held by Qiagen's parent company, Qiagen N.V., a multinational biotechnology firm that provides sample and assay technologies to federal agencies, including the NIH, CDC, VA, and DOD. Qiagen has...
The National Institute of Allergy and Infectious Diseases awarded a $17,013.02 firm fixed-price purchase order to Qiagen, LLC for the QIASEQ FastSelect 5S/16S/23S Kit (384). This contract, awarded on September 16, 2021, with an ultimate completion date of September 24, 2021, represents a straightforward procurement of specialized molecular biology reagents used for ribosomal RNA depletion and sample preparation in next-generation sequencing applications. The award includes no set-aside designation, reflecting the specialized and proprietary nature of Qiagen's diagnostic and molecular biology products. This purchase order was subsequently processed for administrative de-obligation of unexpended and expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552(a) in preparation for the September 30, 2026 closing of the period of availability for these federal funds. Qiagen, LLC, a subsidiary of Netherlands-based Qiagen N.V. and headquartered in Germantown, Maryland, serves as a critical supplier of molecular diagnostics products and bioinformatics solutions across multiple federal agencies. The company maintains an extensive portfolio of indefinite delivery vehicles and blanket purchase agreements valued in the tens of millions of dollars with agencies including the Department of Health and Human Services, Centers for Disease Control and Prevention, Defense Health Agency, Federal Bureau of Investigation, and Veterans Affairs. Qiagen's specialized expertise in DNA and RNA extraction, genomic analysis, and sample preparation positions it as an essential partner for federal research and diagnostic testing initiatives, with contract values ranging from modest task orders to substantial definitive contracts exceeding $900,000.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Funding Only Action | ($70) | 1/26/26 | |
| P00001 | Other Administrative Action | $0 | 7/6/22 | |
| Not listed | Not listed | $17.1k | 9/17/21 |